1. Keogh, Anna, Ryan, Lisa, Nur, Mutaz M, Finn, Stephen P, Gray, Steven G. . USO1 expression is dysregulated in non-small cell lung cancer. In Translational lung cancer research, 11, 1877-1895. doi:10.21037/tlcr-22-230. https://pubmed.ncbi.nlm.nih.gov/36248341/
2. Jin, Yueling, Dai, Zhensheng. 2016. USO1 promotes tumor progression via activating Erk pathway in multiple myeloma cells. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 78, 264-271. doi:10.1016/j.biopha.2016.01.012. https://pubmed.ncbi.nlm.nih.gov/26898451/
3. Yoon, Sarah, Choi, Ji-Hye, Shah, Masaud, Wang, Hee-Jung, Woo, Hyun Goo. . USO1 isoforms differentially promote liver cancer progression by dysregulating the ER-Golgi network. In Carcinogenesis, 42, 1208-1220. doi:10.1093/carcin/bgab067. https://pubmed.ncbi.nlm.nih.gov/34293111/
4. Sui, Jinke, Li, Xu, Xing, Junjie, Gong, Haifeng, Zhang, Wei. 2015. Lentivirus-mediated silencing of USO1 inhibits cell proliferation and migration of human colon cancer cells. In Medical oncology (Northwood, London, England), 32, 218. doi:10.1007/s12032-015-0658-z. https://pubmed.ncbi.nlm.nih.gov/26184508/
5. Jaiswal, Amit Kumar, Truong, Hellen, Tran, Tiffany M, Alberti, Michael O, Rao, Dinesh S. 2021. Focused CRISPR-Cas9 genetic screening reveals USO1 as a vulnerability in B-cell acute lymphoblastic leukemia. In Scientific reports, 11, 13158. doi:10.1038/s41598-021-92448-w. https://pubmed.ncbi.nlm.nih.gov/34162911/
6. Dong, Yan, Xue, Liyan, Zhang, Yan, Lv, Ning, Zhan, Qimin. 2022. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC). In Journal of experimental & clinical cancer research : CR, 41, 150. doi:10.1186/s13046-022-02355-9. https://pubmed.ncbi.nlm.nih.gov/35449073/
智鼠故事 
